vimarsana.com
  1. Home
  2. Live Updates
  3. Bristol Myer Opdivo - Breaking News

Bristol Myer Opdivo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

5 questions facing pharma in 2024

BioPharma

United statesBristol myer opdivoChris viehbacherEli lillyDavid ricksZealand pharmaBristol myersJonathan gardnerMerck keytrudaBristol myerNovo ozempicLilly zepboundNed pagliaruloNovo nordiskMerck coBristol myers squibb

Can cheaper drugs help home-grown labs turn the table on foreign Big Pharma in China s cancer treatment market?

Research and development costs run up against a ceiling over treatment prices, a very pertinent concern in China, where the government is anxious to keep health care affordable, in keeping with its socialist principle of governance

Hong kongLuo jiarongBristol myer opdivoInnovent biologicsBristol myers squibbMichael yu dechaoWu yuJunshi biosciencesEli lillyMerck keytrudaShanghai pharmaceuticals holdingUs federal drug administrationShanghai junshi biosciencesCommunist party ledMyers squibbUnited states based

FDA approves new Bristol Myers drug for lung cancer

BioPharma

Bristol myer opdivoBristol myerBristol myersRoche rozlytrekDrug administration onMerck coBristol myers squibbDive briefDrug administrationTurning point therapeutics

A biotech scraps two cancer trials in latest setback for emerging drug class

BioPharma

Bristol myer opdivoMerck coBristol myers squibbGilead sciencesDive briefTrillium therapeutics

Merck gets a surprise win for Keytruda in early lung cancer

BioPharma

United statesBristol myer opdivoBristol myers squibb opdivoRoche tecentriqDaina grayboschDrug administrationMerck coAmerican cancer societyAmerican cancerBristol myers squibbBiopharma dive

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.